Submit a story
Tell us your story.
GSK said on Monday its blood cancer drug Blenrep, when used as a second-line treatment in patients with myeloma, met its primary goal.
The Fed is widely expected to leave interest rates on hold as it assesses how its historic bout of monetary tightening is impacting inflation.
GSK said it is still firmly growing despite the significant reduction in sales of Covid-19 products over recent years.
Pharmaceutical giant GSK said today it has reached a "confidential settlement" over several lawsuits filed in California.
GSK has pocketed £886m after offloading a chunk of its stake in the spun off consumer healthcare arm Haleon, the firm announced this morning. The FTSE 100 healthcare giant announced yesterday that it would sell some 270m in ordinary shares at a price of 328p per share. The sale has now slashed the size of [...]
GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines. The strong results may further help revive investor confidence in CEO Emma Walmsley, coming a year after the company spun off its consumer health business, Haleon, in its most [...]
Pharmaceutical giant GSK has revealed it has settled a lawsuit relating to discontinued heartburn drug Zantac, which was alleged to be linked to cancer. Shares in GSK jumped after it said an upcoming trial was cancelled but that it does not admit liability. The company hit back at allegations last year that the use of [...]
British drugmaker GlaxoSmithKline (GSK) has today offloaded some 240m shares of its spun out consumer healthcare group Haleon in a move which has raised £804m for the firm.
A “strong” cold and flu season and the end of Chinese lockdowns contributed to a healthy revenue boost for Haleon, the spin-out of GSK’s consumer healthcare division. Organic revenues within the group were up 9.9 per cent, with operating profit hitting £627m – reflecting a large reduction in the costs of spinning out the business [...]
Drugs giant GSK has posted better-than-forecast revenues for the first quarter thanks to strong sales of its shingles vaccine and HIV medicines. The FTSE 100 group saw earnings fall 15 per cent on a constant currency basis to £2.1bn in the first quarter as revenues dropped eight per cent to £7bn after sales of its Covid-19 treatment [...]
Subscribe to the City A.M. newsletter to have our top stories delivered directly to your inbox.
Subscribe to get the essential daily news updates from City A.M's top stories to your inbox.